Literature DB >> 2270743

Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden.

A Svenningsson1, B Runmarker, J Lycke, O Andersen.   

Abstract

The average annual incidence of definite and probable MS in Gothenburg was re-investigated. For 1950-1954, 1955-1959 and 1960-1964 it was 4.2, 4.2 and 4.3/100,000/year. For the five-year periods between 1974 and 1988 it was 3.0, 2.7 and 2.0/100,000/year. If possible MS was included, the corresponding incidence for 1950-1964 was 5.2, 5.3 and 5.1, and for 1974-1988 it was 3.9, 3.9 and 4.3/100,000/year. Neurological methods and diagnostic criteria were constant throughout the period. The 1950-1964 incidence was based on personally investigated cases, while the 1974-1988 incidence was based partly on review of Gothenburg neurology records. It is concluded that there has been a significant decrease in the incidence of MS in this area. However, the notified decrease may partly be explained by alterations in the case ascertainment procedure. Since the Swedish measles vaccination program started in 1971, the occurrence of measles has been declining and has practically ceased during the 1980s. The time when a possible influence of mass vaccinations against childhood diseases on MS incidence can be monitored is discussed.

Mesh:

Substances:

Year:  1990        PMID: 2270743     DOI: 10.1111/j.1600-0404.1990.tb04483.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  17 in total

1.  The risk for multiple sclerosis in female nurse anaesthetists: a register based study.

Authors:  A-M Landtblom; M Tondel; P Hjalmarsson; U Flodin; O Axelson
Journal:  Occup Environ Med       Date:  2006-06       Impact factor: 4.402

Review 2.  Clinical prognostic factors in multiple sclerosis: a natural history review.

Authors:  Alexandra Degenhardt; Sreeram V Ramagopalan; Antonio Scalfari; George C Ebers
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

3.  Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden.

Authors:  P Sundström; L Nyström; L Forsgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

Review 4.  Role of "Western diet" in inflammatory autoimmune diseases.

Authors:  Arndt Manzel; Dominik N Muller; David A Hafler; Susan E Erdman; Ralf A Linker; Markus Kleinewietfeld
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

5.  Surveying multiple sclerosis in the United Kingdom.

Authors:  N Robertson; A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

6.  HLA and prognosis in multiple sclerosis.

Authors:  B Runmarker; T Martinsson; J Wahlström; O Andersen
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

7.  Multiple sclerosis in nurse anaesthetists.

Authors:  U Flodin; A-M Landtblom; O Axelson
Journal:  Occup Environ Med       Date:  2003-01       Impact factor: 4.402

8.  Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study.

Authors:  O Andersen; P E Lygner; T Bergström; M Andersson; A Vahlne
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

Review 9.  Temporal trends in the incidence of multiple sclerosis: a systematic review.

Authors:  Alvaro Alonso; Miguel A Hernán
Journal:  Neurology       Date:  2008-07-08       Impact factor: 9.910

10.  Prediction of outcome in multiple sclerosis based on multivariate models.

Authors:  B Runmarker; C Andersson; A Odén; O Andersen
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.